News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 223592

Monday, 04/22/2019 10:20:15 AM

Monday, April 22, 2019 10:20:15 AM

Post# of 257253
FDA approves Ketyruda/Inlyta in 1L-RCC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-104500869.html

The RCC battle lines are set: Opdivo/Yervoy vs Keytruda/Inlyta.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now